129 related articles for article (PubMed ID: 24134330)
1. Using noninvasive hemoglobin measurements to estimate measured hemoglobin in a pediatric hemodialysis unit.
Stavinoha A; Modem V; Quigley R
Hemodial Int; 2013 Oct; 17 Suppl 1():S7-10. PubMed ID: 24134330
[TBL] [Abstract][Full Text] [Related]
2. CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients.
Garro R; Sutherland S; Bayes L; Alexander S; Wong C
Pediatr Nephrol; 2015 Jun; 30(6):991-8. PubMed ID: 25854612
[TBL] [Abstract][Full Text] [Related]
3. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin variability in chronic kidney disease: a cross-sectional study.
Spiegel DM
Am J Med Sci; 2009 May; 337(5):340-3. PubMed ID: 19295412
[TBL] [Abstract][Full Text] [Related]
5. Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients.
Kusaba T; Ishida R; Nakayama M; Kato H; Uchiyama H; Sato K; Mori Y; Matsubara H; Kajita Y
Arzneimittelforschung; 2009; 59(9):435-9. PubMed ID: 19856789
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting anemia management in hemodialysis patients: a single-center experience.
Spiegel DM; Gitlin M; Mayne T
Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of noninvasive hemoglobin monitoring in patients at risk for hemorrhage.
Tsuei BJ; Hanseman DJ; Blakeman MJ; Blakeman TC; Yang SH; Branson RD; Gerlach TW
J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S134-9. PubMed ID: 25159346
[TBL] [Abstract][Full Text] [Related]
8. Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin.
Geer JJ; Braun MC; Srivaths PR
Pediatr Nephrol; 2015 Apr; 30(4):661-4. PubMed ID: 25322906
[TBL] [Abstract][Full Text] [Related]
9. Transforming hemoglobin measurement in trauma patients: noninvasive spot check hemoglobin.
Joseph B; Pandit V; Aziz H; Kulvatunyou N; Zangbar B; Tang A; O' Keeffe T; Jehangir Q; Snyder K; Rhee P
J Am Coll Surg; 2015 Jan; 220(1):93-8. PubMed ID: 25456784
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
Agarwal R; Davis JL; Smith L
Clin J Am Soc Nephrol; 2008 Jan; 3(1):98-104. PubMed ID: 18045859
[TBL] [Abstract][Full Text] [Related]
11. [Hemoglobin variability in patients with chronic renal insuffiency].
Deray G
Nephrol Ther; 2008 Dec; 4(7):549-52. PubMed ID: 19004677
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Hemoglobin Monitoring: A Rapid, Reliable, and Cost-Effective Method Following Total Joint Replacement.
Martin JR; Camp CL; Stitz A; Young EY; Abdel MP; Taunton MJ; Trousdale RT
J Bone Joint Surg Am; 2016 Mar; 98(5):349-55. PubMed ID: 26935456
[TBL] [Abstract][Full Text] [Related]
13. Impact of the change in CMS billing rules for erythropoietin on hemoglobin outcomes in dialysis patients.
Ofsthun NJ; Lazarus JM
Blood Purif; 2007; 25(1):31-5. PubMed ID: 17170534
[TBL] [Abstract][Full Text] [Related]
14. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
15. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.
Brunelli SM; Lynch KE; Ankers ED; Joffe MM; Yang W; Thadhani RI; Feldman HI
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1733-40. PubMed ID: 18922985
[TBL] [Abstract][Full Text] [Related]
16. Anemia Management in the China Dialysis Outcomes and Practice Patterns Study.
Zuo L; Wang M; Hou F; Yan Y; Chen N; Qian J; Wang M; Bieber B; Pisoni RL; Robinson BM; Anand S
Blood Purif; 2016; 42(1):33-43. PubMed ID: 27045519
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis.
Fuertinger DH; Kappel F; Zhang H; Thijssen S; Kotanko P
PLoS One; 2018; 13(4):e0195918. PubMed ID: 29668766
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
19. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
20. A comparison of methods for the measurement of hemodialysis access recirculation and access blood flow rate.
Lindsay RM; Bradfield E; Rothera C; Kianfar C; Malek P; Blake PG
ASAIO J; 1998; 44(1):62-7. PubMed ID: 9466503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
